Pharmacokinetic Evaluation of Oral Viscous Budesonide in Paediatric Patients with Eosinophilic Oesophagitis in Repaired Oesophageal Atresia

Eosinophilic oesophagitis is a long-term complication of oesophageal atresia (EA), an uncommon condition that affects approximately 1 in 3500 infants. An exploratory, open-label phase 2 clinical trial was conducted in paediatric eosinophilic oesophagitis after oesophageal atresia (EoE-EA) to assess...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Raffaele Simeoli, Sebastiano A. G. Lava, Alessandro Di Deo, Marco Roversi, Sara Cairoli, Renato Tambucci, Francesca Rea, Monica Malamisura, Giulia Angelino, Isabella Biondi, Alessandra Simonetti, Paola De Angelis, Carlo Dionisi Vici, Paolo Rossi, Giuseppe Pontrelli, Oscar Della Pasqua, Bianca Maria Goffredo
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2024-06-01
Цуврал:	Pharmaceutics
Нөхцлүүд:	eosinophilic oesophagitis (EoE) oesophageal atresia (EA) pharmacokinetics oral viscous budesonide population pharmacokinetic modelling systemic absorption
Онлайн хандалт:	https://www.mdpi.com/1999-4923/16/7/872
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!